Arcus Biosciences Inc (RCUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 1,250 | 1,253 | 163 | 0 | 0 |
| Gross Profit | 1,250 | 1,253 | 163 | N/A | N/A |
| Operating Expenses | 14,581 | 14,614 | 23,297 | 9,664 | 7,300 |
| Operating Income | -13,331 | -13,361 | -23,134 | -9,664 | -7,300 |
| Other Income | 377 | 149 | 12 | 114 | 100 |
| Pre-tax Income | -12,954 | -13,212 | -23,122 | -9,550 | -7,200 |
| Net Income Continuous | -12,954 | -13,212 | -23,122 | -9,550 | -7,200 |
| Net Income | $-12,954 | $-13,212 | $-23,122 | $-9,550 | $-7,200 |
| EPS Basic Total Ops | -1.37 | -6.57 | -11.86 | -5.64 | -4.96 |
| EPS Basic Continuous Ops | -1.37 | -6.58 | -11.86 | -5.64 | -4.96 |
| EPS Diluted Total Ops | -1.37 | -6.57 | -11.86 | -5.64 | -4.96 |
| EPS Diluted Continuous Ops | -1.37 | -6.58 | -11.86 | -5.64 | -4.96 |
| EBITDA(a) | $-12,503 | $-12,677 | $-22,320 | $-9,036 | $-6,814 |